PMID- 37767310 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20230929 IS - 2341-4545 (Print) IS - 2387-1954 (Electronic) IS - 2387-1954 (Linking) VI - 30 IP - 4 DP - 2023 Aug TI - Side-Viewing Duodenoscope versus Forward-Viewing Gastroscope for Endoscopic Retrograde Cholangiopancreatography in Billroth II Gastrectomy Patients. PG - 267-274 LID - 10.1159/000524262 [doi] AB - INTRODUCTION: Endoscopic retrograde cholangiopancreatography (ERCP) in patients with Billroth II gastrectomy is still a challenging procedure. The optimal approach, namely the type of endoscope and sphincter management, has yet to be defined. AIM: To compare the efficacy and safety of forward-viewing gastroscope and the side-viewing duodenoscope in ERCP of patients with Billroth II gastrectomy. METHODS: We conducted a retrospective, single-center cohort study of consecutive patients with Billroth II gastrectomy submitted to ERCP in an expert center for ERCP between 2005 and 2021. The outcomes assessed were: papilla identification, deep biliary cannulation, and adverse events (AEs). Multivariate analysis was performed to evaluate potential associations and predictors of the main outcomes. RESULTS: We included 83 patients with a median age of 73 (IQR 65-81) years. ERCP was performed using side-viewing duodenoscope in 52 and forward-viewing gastroscope in 31 patients. Patients' characteristics were similar in the two groups. The global rate of papilla identification was 66% (n = 55). The rate of deep cannulation was 58% considering all patients and 87% in the subgroup of patients in which the papilla major was identified. Cannulation was performed with standard methods in 65% of cases and with needle-knife fistulotomy in 35%. AEs occurred in 4 patients. There was no difference between duodenoscope and gastroscope in papilla identification (64% [95% CI: 51-77] vs. 71% [55-87]). Although not statistically significant, duodenoscope had a lower deep cannulation rate when considering all patients (52% [15-39] vs. 68% [7-35]) and a higher AEs rate (8% [1-15] vs. 0% [0-1]). In a multivariate analysis, the use of gastroscope significantly increased the deep cannulation rate (OR = 152.62 [2.5-9,283.6]). CONCLUSION: This study demonstrates that forward-viewing gastroscope is at least as effective and safe as side-viewing duodenoscope for ERCP in patients with Billroth II gastrectomy. Moreover, our study showed that gastroscope is an independent predictor of successful cannulation. CI - Copyright (c) 2022 by Sociedade Portuguesa de Gastrenterologia. Published by S. Karger AG, Basel. FAU - Marques de Sa, Ines AU - Marques de Sa I AD - Department of Gastroenterology, Portuguese Oncology Institute of Porto, Porto, Portugal. FAU - Chaves, Carlos Borges AU - Chaves CB AD - Department of Gastroenterology, Hospital Santa Luzia, Viana do Castelo, Portugal. FAU - Correia de Sousa, Joao AU - Correia de Sousa J AD - Department of Gastroenterology, Hospital das Forcas Armadas, Porto, Portugal. FAU - Fernandes, Joao AU - Fernandes J AD - Department of Gastroenterology, Hospital Santa Luzia, Viana do Castelo, Portugal. FAU - Araujo, Tarcisio AU - Araujo T AD - Department of Gastroenterology, Hospital Santa Luzia, Viana do Castelo, Portugal. FAU - Canena, Jorge AU - Canena J AD - Department of Gastroenterology, Professor Doutor Fernando Fonseca Hospital, Amadora, Portugal. AD - Department of Gastroenterology, Nova Medical School-Faculty of Medical Sciences, Lisbon, Portugal. FAU - Lopes, Luis AU - Lopes L AD - Department of Gastroenterology, Hospital Santa Luzia, Viana do Castelo, Portugal. AD - Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal. AD - ICVS/3B's - PT Government Associate Laboratory, Braga/Guimaraes, Portugal. LA - eng PT - Journal Article DEP - 20220510 PL - Switzerland TA - GE Port J Gastroenterol JT - GE Portuguese journal of gastroenterology JID - 101685861 PMC - PMC10521316 OTO - NOTNLM OT - Billroth II operation OT - Duodenoscope OT - Endoscopic retrograde cholangiopancreatography OT - Gastroscope COIS- The authors declare no conflicts of interest. EDAT- 2022/05/10 00:00 MHDA- 2022/05/10 00:01 PMCR- 2022/05/10 CRDT- 2023/09/28 04:14 PHST- 2021/09/27 00:00 [received] PHST- 2022/01/17 00:00 [accepted] PHST- 2022/05/10 00:01 [medline] PHST- 2022/05/10 00:00 [pubmed] PHST- 2023/09/28 04:14 [entrez] PHST- 2022/05/10 00:00 [pmc-release] AID - pjg-0030-0267 [pii] AID - 10.1159/000524262 [doi] PST - epublish SO - GE Port J Gastroenterol. 2022 May 10;30(4):267-274. doi: 10.1159/000524262. eCollection 2023 Aug.